Cravens & Co Advisors, LLC
- SEC CIK
- 0001966116
- Latest filing
- Aug 12, 2026
NVS holding history
Novartis AG in every 13F filed by Cravens & Co Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NVS overviewAll 13F holders of NVSFull Q2 2026 holdings
- Shares (Q3 2024)
- 0
- Sold out in Q3 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 7
- Since Q4 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2024 | 0 | $0 | 0.0% | −3,507−100.0% | Sold out | Holders |
| Q2 2024 | 3,507 | $373.4K | 0.3% | 00.0% | Unchanged | Holders |
| Q1 2024 | 3,507 | $339.2K | 0.3% | 00.0% | Unchanged | Holders |
| Q4 2023 | 3,507 | $354.1K | 0.3% | 00.0% | Unchanged | Holders |
| Q3 2023 | 3,507 | $357.2K | 0.3% | 00.0% | Unchanged | Holders |
| Q2 2023 | 3,507 | $353.9K | 0.3% | 00.0% | Unchanged | Holders |
| Q1 2023 | 3,507 | $322.6K | 0.3% | 00.0% | Unchanged | Holders |
| Q4 2022 | 3,507 | $318.2K | 0.3% | – | No prior filing | Holders |